Breakthrough Gene-Editing Drug Reduces Bad Cholesterol by 62%
This one-shot drug cut bad cholesterol by 62%. Why doctors are watching closely
Image: The Times Of India
A new gene-editing drug, VERVE-102, developed by Eli Lilly, has shown promise in reducing 'bad' cholesterol by 62% with a single infusion. This could transform heart disease management from ongoing treatment to a one-time solution, pending further studies.
- 01VERVE-102 is an experimental gene-editing medicine by Eli Lilly.
- 02The drug permanently alters a liver gene to lower bad cholesterol levels.
- 03Initial results indicate a 62% reduction in bad cholesterol for at least one year.
- 04This treatment could change cardiovascular care significantly.
- 05Larger studies are needed to confirm these early findings.
Advertisement
In-Article Ad
A groundbreaking development in cardiovascular treatment has emerged with the experimental gene-editing drug VERVE-102, created by Eli Lilly. Early results show that a single infusion of this drug can lead to a 62% reduction in 'bad' cholesterol levels, potentially lasting for at least a year. This innovative approach permanently edits a liver gene, which could revolutionize the management of heart disease by shifting from continuous treatment to a one-time intervention. If these promising results are validated in larger clinical trials, VERVE-102 may significantly alter how cardiovascular care is approached, offering hope to millions at high risk of heart disease.
Advertisement
In-Article Ad
If successful, VERVE-102 could significantly reduce the need for ongoing cholesterol management in patients at high risk of heart disease.
Advertisement
In-Article Ad
Reader Poll
What do you think about gene-editing treatments for cholesterol management?
Connecting to poll...
More about Eli Lilly
La Chine renforce sa collaboration avec des entreprises pharmaceutiques étrangères
Investing French • May 22, 2026
Neues Abnehmmittel Retatrutide übertrifft bisherige Gewichtsverlust-Standards
Ntv • May 22, 2026
Eli Lilly's New Obesity Drug Shows Promising Weight Loss Results in Trials
The Hill • May 22, 2026
Read the original article
Visit the source for the complete story.